In our preclinical studies of both GBM and peripheral cancers, we have noticed a profound role of TAMs in initiating a cascade of events involving activated NKp46+ NK cells and CD68+ Tc cells [15,19,20,23]. This evidence concerns the gene CD68 and glioblastoma.